FLT4 and neoplasm: Ultimately, our study demonstrated that MDSCs are sensitive to the tumor microenvironment in which they reside, particularly indicating that interstitial flow leads to enhanced migration when lymphatic endothelial cells are present and targeting of VEGFR3 may be a tractable mechanism to reduce both MDSC and tumor cell migration and, potentially, metastatic spread of disease.